Skip to Main content Skip to Navigation
Journal articles

Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.: Stem cell therapy for respiratory disease.

Abstract : Interest has increased in the use of exogenous stem cells to optimize lung repair and serve as carriers of a therapeutic gene for genetic airway diseases such as cystic fibrosis. We investigated the survival and engraftment of exogenous stem cells after intratracheal injection, in a murine model of acute epithelial airway injury already used in gene therapy experiments on cystic fibrosis. Embryonic stem cells and mesenchymal stem cells were intratracheally injected 24 hr after 2% polidocanol administration, when epithelial airway injury was maximal. Stem cells were transfected with reporter genes immediately before administration. Reporter gene expression was analyzed in trachea-lungs and bronchoalveolar lavage, using nonfluorescence, quantitative, and sensitive methods. Enzyme-linked immunosorbent assay quantitative results showed that 0.4 to 5.5% of stem cells survived in the injured airway. Importantly, no stem cells survived in healthy airway or in the epithelial lining fluid. Using 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside staining, transduced mesenchymal stem cells were detected in injured trachea and bronchi lumen. When the epithelium was spontaneously regenerated, the in vivo amount of engrafted mesenchymal stem cells from cell lines decreased dramatically. No stem cells from primary culture were located within the lungs at 7 days. This study demonstrated the feasibility of intratracheal cell delivery for airway diseases with acute epithelial injury.
Document type :
Journal articles
Complete list of metadatas

Cited literature [27 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00407987
Contributor : Patricia Lemarchand <>
Submitted on : Friday, October 21, 2011 - 1:52:13 PM
Last modification on : Wednesday, December 2, 2020 - 3:18:03 PM
Long-term archiving on: : Sunday, January 22, 2012 - 2:20:23 AM

Files

inserm-00407987_edited.pdf
Files produced by the author(s)

Identifiers

Citation

Anne-Laure Leblond, Patrice Naud, Virginie Forest, Clothilde Gourden, Christine Sagan, et al.. Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.: Stem cell therapy for respiratory disease.. Human Gene Therapy, Mary Ann Liebert, 2009, 20 (11), pp.1329-43. ⟨10.1089/hum.2009.035⟩. ⟨inserm-00407987⟩

Share

Metrics

Record views

701

Files downloads

1976